ArticleBMC neurology2026
Mid-to-late-life social network size and resilience to neurodegeneration: The Framingham Heart Study.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSocial stimulation from having large networks may build cognitive reserve and contribute to cognitive resilience. However, limited research has assessed whether this relationship differs across the adult life course. We examined the relationship between social network size and resilience to neurodegeneration in memory, language, and executive function among mid-to-late-life adults.
methodsThe sample included 1,602 participants from the Framingham Heart Study Offspring cohort who completed the Berkman-Syme Social Network Index (SNI) questionnaire, had available plasma total tau (t-tau) measures at Exam 8, and had neuropsychological (NP) factor scores in memory, language, and executive function. Social network size was operationalized through a calculated SNI score and categorized into small, medium, and large networks. Cognitive resilience was operationalized using a residual approach by regressing each NP factor score on the plasma t-tau measure. Linear regression was used to assess associations between social network size and cognitive resilience, adjusting for age, sex, education, APOE ε4 allele carrier status, time between the most recent NP exam visit date and Exam 8 date, physical activity, smoking status, and depressive symptoms. Models were stratified by midlife (age 47-64 years) and late-life (age 65-91 years) groups.
resultsAverage age was 67 years with most participants identifying as female (n = 880; 55%). By age group, more participants were in the late-life group (n = 918; 57%) compared to the midlife group (n = 684; 43%). Large social network size was significantly associated with greater resilience to neurodegeneration in memory compared to small social network size (β = 0.07; 95% CI = 0.01-0.13). There were no significant associations between large social networks and resilience to neurodegeneration in language or executive function. No significant interactions between social network size and age group on resilience to neurodegeneration were observed in any of the domains examined. In the stratified models, large social networks were only associated with resilience to neurodegeneration in executive function among the midlife group (β = 0.11; 95% CI = 0.01-0.21).
conclusionsLarge social networks may promote greater resilience to neurodegeneration in memory among mid-to-late-life adults. Specific to middle-aged adults was a significantly greater resilience in executive function associated with large networks. These findings should be interpreted with caution, however, as estimate sizes are relatively small and potentially not robust, given the current sample size. Additional studies in larger and more diverse samples are needed to replicate and generalize our findings to other groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.